Stergiou Angelos M.
- SEC CIK
- 0001724253
No open-market purchases or sales filed in the past year.
Current role at each company
- SLS SELLAS Life Sciences Group, Inc.President and CEOas of Jun 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stergiou Angelos M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 (view filing) | Dec 5 | Same day | Stergiou Angelos M.President and CEO | SSaleClass A Common Stock | −6.49K | $2.61 | −$16.9K | −3.9%161.7K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Stergiou Angelos M.President and CEO | SSale | −2.12K | $6.25 | −$13.3K | −1.7%121.2K after |